Aktien Sensor

AbbVie Inc. has reported strong quarterly earnings, driven by the success of its flagship products Skyrizi and Rinvoq, sending its stock price surging.

Bayer’s stock price has skyrocketed after the company’s revised revenue forecast, driven by its pharmaceutical segment and a bold move to set aside funds for glyphosate lawsuits.

Novo Nordisk A-S faces intensifying competition, leading to a decline in stock price, but a new cost-defraying option has sparked optimism among investors.

AstraZeneca’s stock price has fluctuated due to market trends and external factors, but analysts remain optimistic about the company’s potential for growth.

GSK PLC reports strong quarterly earnings, with profit per share and revenue increasing significantly compared to the same period last year.

Amgen Inc. has announced a third quarter dividend and will report its second quarter financial results, despite market volatility, with its focus on innovative medicines and patient outcomes driving long-term growth prospects.

Genmab A/S, a biotechnology company, has seen its stock price plummet due to market turbulence triggered by the US president’s call for lower medicine prices.

United Therapeutics’ quarterly earnings report showed revenue growth, but the company fell short of analyst expectations, leading to a decline in its stock price.

Mettler-Toledo International Inc. reported a 5% increase in earnings per share in its second-quarter earnings report, exceeding market estimates.

Avantor Inc’s disappointing second-quarter earnings report highlights the challenges facing the chemicals industry, with the company’s stock price taking a hit as it struggles to adapt to a rapidly changing market.